Nov 9, 2018

The pro-oncogenic adaptor CIN85 inhibits hypoxia-inducible factor prolyl hydroxylase-2

BioRxiv : the Preprint Server for Biology
Nina KozlovaThomas Kietzmann

Abstract

The family of HIF-prolyl hydroxylases is crucially involved in the regulation of hypoxia-inducible factor (HIF) levels. We have previously shown that the EGFR-adaptor protein CIN85 promotes breast cancer malignancy and HIF-1α stability. These findings suggested that the CIN85-mediated effects occur via interference of proline hydroxylase (PHD)-dependent HIF-α protein degradation and involve a molecular association between CIN85 and PHDs. Indeed, our current study identified CIN85 as a novel binding partner of the main HIF-prolyl hydroxylase PHD2, but not of PHD1 or PHD3. We defined the importance of the N-terminal SH3 domains of CIN85 and the proline-arginine rich region within the amino acids 77-100 in the N-terminus of PHD2 for CIN85-PHD2 complex formation.

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Study
EGFR
EGLN1
Protein Degradation, Regulatory
Hypoxia-Inducible Factor Prolyl Hydroxylase 2
SH3KBP1 gene
Regulation of Biological Process
Endothelial PAS domain-containing protein 1
Amino Acids, I.V. solution additive
Epidermal Growth Factor Receptor Activity

About this Paper

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.